You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Johnson and Johnson
Baxter
McKinsey
Merck

Last Updated: November 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Trades Services MN Welfare Fund v. AbbVie Inc. (N.D. Ill. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Trades Services MN Welfare Fund v. AbbVie Inc. (N.D. Ill. 2019)

Docket   Start Trial Date Filed 2019-03-29
Court District Court, N.D. Illinois Date Terminated
Cause 15:1 Antitrust Litigation Assigned To Thomas Michael Durkin
Jury Demand Plaintiff Referred To
Parties ABBVIE BIOTECHNOLOGY LTD.
Patents 7,820,799; 8,093,045; 8,663,945; 8,911,964; 8,926,975; 8,961,973; 8,986,693; 9,018,361; 9,067,992; 9,090,689; 9,090,867; 9,096,666; 9,187,559; 9,255,143; 9,266,949; 9,359,434; 9,365,645; 9,512,216
Attorneys Katrina Carroll
Firms Lite DePalma Greenberg LLC
Link to Docket External link to docket
Biologic Drugs cited in Trades Services MN Welfare Fund v. AbbVie Inc.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Trades Services MN Welfare Fund v. AbbVie Inc. (N.D. Ill. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-03-29 1 Complaint in light of U.S. Patent No. 5,429,746 and a publication of U.S. Patent No. 7,820,799. Although it does…second patent not patentably distinct from claims in a first patent.”22 52. Patent prosecutions… original patent filings. However, for these secondary patent filings, the original patents become “prior…of AbbVie’s use patents and found three patents invalid due to obviousness: U.S. Patent No. 8,889,135;…non-inventive patents for the purpose of developing a ‘patent thicket,’ using the patenting process itself External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
McKinsey
McKesson
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.